| Heather Hefner, FNP-C | |
|
3617 N 103rd Dr, Avondale, AZ 85392-4477 | |
| (972) 935-3444 | |
| Not Available |
| Full Name | Heather Hefner |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 3617 N 103rd Dr, Avondale, Arizona |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336784446 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 231614 (Arizona) | Primary |
| Entity Name | Arizona Em-i Medical Services Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750596771 PECOS PAC ID: 8325034812 Enrollment ID: O20040421000835 |
News Archive
SRI International, an independent nonprofit research and development institute, announced today that Dr. Elizabeth Shriberg, a senior researcher in SRI's Speech Technology and Research (STAR) Laboratory, has been named a Fellow of the International Speech Communication Association (ISCA).
Pregnancy hypertension, or Pre-eclampsia, is a complex disorder of pregnancy. Treatment of elevated blood pressure can manage the condition in the mother, but in severe cases delivery is needed, which can present a major problem to the baby if it is born prematurely.
Avila Therapeutics™, Inc., a biotechnology company developing targeted covalent drugs that treat diseases through protein silencing, presented results of preclinical studies on two of its Hepatitis C Virus protease inhibitors, AVL-181 and AVL-192. These inhibitors, due to their unique mechanism of action with superior selectivity and potency, have potential as best-in-class, pan-genotype HCV therapeutics.
OmniVision Technologies, Inc., a leading developer of advanced digital imaging solutions, today announced a new ultra-compact CameraChip sensor for medical and industrial applications.
Capstone Therapeutics announced today it has completed a limited analysis of a subset of data from its ongoing AZX100 Phase 2a clinical trial in trocar site scarring following arthroscopic shoulder surgery. Based on this analysis, the clinical trial will continue to its planned 12-month endpoints.
› Verified 1 days ago
| Entity Name | Arizona Emergency Medicine Specialists Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134439706 PECOS PAC ID: 8921295684 Enrollment ID: O20110208000837 |
News Archive
SRI International, an independent nonprofit research and development institute, announced today that Dr. Elizabeth Shriberg, a senior researcher in SRI's Speech Technology and Research (STAR) Laboratory, has been named a Fellow of the International Speech Communication Association (ISCA).
Pregnancy hypertension, or Pre-eclampsia, is a complex disorder of pregnancy. Treatment of elevated blood pressure can manage the condition in the mother, but in severe cases delivery is needed, which can present a major problem to the baby if it is born prematurely.
Avila Therapeutics™, Inc., a biotechnology company developing targeted covalent drugs that treat diseases through protein silencing, presented results of preclinical studies on two of its Hepatitis C Virus protease inhibitors, AVL-181 and AVL-192. These inhibitors, due to their unique mechanism of action with superior selectivity and potency, have potential as best-in-class, pan-genotype HCV therapeutics.
OmniVision Technologies, Inc., a leading developer of advanced digital imaging solutions, today announced a new ultra-compact CameraChip sensor for medical and industrial applications.
Capstone Therapeutics announced today it has completed a limited analysis of a subset of data from its ongoing AZX100 Phase 2a clinical trial in trocar site scarring following arthroscopic shoulder surgery. Based on this analysis, the clinical trial will continue to its planned 12-month endpoints.
› Verified 1 days ago
| Entity Name | Four Corners Emergency Physicians Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144793464 PECOS PAC ID: 5092053769 Enrollment ID: O20190205003475 |
News Archive
SRI International, an independent nonprofit research and development institute, announced today that Dr. Elizabeth Shriberg, a senior researcher in SRI's Speech Technology and Research (STAR) Laboratory, has been named a Fellow of the International Speech Communication Association (ISCA).
Pregnancy hypertension, or Pre-eclampsia, is a complex disorder of pregnancy. Treatment of elevated blood pressure can manage the condition in the mother, but in severe cases delivery is needed, which can present a major problem to the baby if it is born prematurely.
Avila Therapeutics™, Inc., a biotechnology company developing targeted covalent drugs that treat diseases through protein silencing, presented results of preclinical studies on two of its Hepatitis C Virus protease inhibitors, AVL-181 and AVL-192. These inhibitors, due to their unique mechanism of action with superior selectivity and potency, have potential as best-in-class, pan-genotype HCV therapeutics.
OmniVision Technologies, Inc., a leading developer of advanced digital imaging solutions, today announced a new ultra-compact CameraChip sensor for medical and industrial applications.
Capstone Therapeutics announced today it has completed a limited analysis of a subset of data from its ongoing AZX100 Phase 2a clinical trial in trocar site scarring following arthroscopic shoulder surgery. Based on this analysis, the clinical trial will continue to its planned 12-month endpoints.
› Verified 1 days ago
| Entity Name | Exceptional Physician Group Arizona, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447910229 PECOS PAC ID: 0042605008 Enrollment ID: O20220310000502 |
News Archive
SRI International, an independent nonprofit research and development institute, announced today that Dr. Elizabeth Shriberg, a senior researcher in SRI's Speech Technology and Research (STAR) Laboratory, has been named a Fellow of the International Speech Communication Association (ISCA).
Pregnancy hypertension, or Pre-eclampsia, is a complex disorder of pregnancy. Treatment of elevated blood pressure can manage the condition in the mother, but in severe cases delivery is needed, which can present a major problem to the baby if it is born prematurely.
Avila Therapeutics™, Inc., a biotechnology company developing targeted covalent drugs that treat diseases through protein silencing, presented results of preclinical studies on two of its Hepatitis C Virus protease inhibitors, AVL-181 and AVL-192. These inhibitors, due to their unique mechanism of action with superior selectivity and potency, have potential as best-in-class, pan-genotype HCV therapeutics.
OmniVision Technologies, Inc., a leading developer of advanced digital imaging solutions, today announced a new ultra-compact CameraChip sensor for medical and industrial applications.
Capstone Therapeutics announced today it has completed a limited analysis of a subset of data from its ongoing AZX100 Phase 2a clinical trial in trocar site scarring following arthroscopic shoulder surgery. Based on this analysis, the clinical trial will continue to its planned 12-month endpoints.
› Verified 1 days ago
| Entity Name | Exceptional Physicians Group Yuma Hospital Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235857699 PECOS PAC ID: 3173983186 Enrollment ID: O20230721000455 |
News Archive
SRI International, an independent nonprofit research and development institute, announced today that Dr. Elizabeth Shriberg, a senior researcher in SRI's Speech Technology and Research (STAR) Laboratory, has been named a Fellow of the International Speech Communication Association (ISCA).
Pregnancy hypertension, or Pre-eclampsia, is a complex disorder of pregnancy. Treatment of elevated blood pressure can manage the condition in the mother, but in severe cases delivery is needed, which can present a major problem to the baby if it is born prematurely.
Avila Therapeutics™, Inc., a biotechnology company developing targeted covalent drugs that treat diseases through protein silencing, presented results of preclinical studies on two of its Hepatitis C Virus protease inhibitors, AVL-181 and AVL-192. These inhibitors, due to their unique mechanism of action with superior selectivity and potency, have potential as best-in-class, pan-genotype HCV therapeutics.
OmniVision Technologies, Inc., a leading developer of advanced digital imaging solutions, today announced a new ultra-compact CameraChip sensor for medical and industrial applications.
Capstone Therapeutics announced today it has completed a limited analysis of a subset of data from its ongoing AZX100 Phase 2a clinical trial in trocar site scarring following arthroscopic shoulder surgery. Based on this analysis, the clinical trial will continue to its planned 12-month endpoints.
› Verified 1 days ago
| Entity Name | Exceptional Physicians Group Bullhead City Hospital Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518732023 PECOS PAC ID: 9335599604 Enrollment ID: O20231228002414 |
News Archive
SRI International, an independent nonprofit research and development institute, announced today that Dr. Elizabeth Shriberg, a senior researcher in SRI's Speech Technology and Research (STAR) Laboratory, has been named a Fellow of the International Speech Communication Association (ISCA).
Pregnancy hypertension, or Pre-eclampsia, is a complex disorder of pregnancy. Treatment of elevated blood pressure can manage the condition in the mother, but in severe cases delivery is needed, which can present a major problem to the baby if it is born prematurely.
Avila Therapeutics™, Inc., a biotechnology company developing targeted covalent drugs that treat diseases through protein silencing, presented results of preclinical studies on two of its Hepatitis C Virus protease inhibitors, AVL-181 and AVL-192. These inhibitors, due to their unique mechanism of action with superior selectivity and potency, have potential as best-in-class, pan-genotype HCV therapeutics.
OmniVision Technologies, Inc., a leading developer of advanced digital imaging solutions, today announced a new ultra-compact CameraChip sensor for medical and industrial applications.
Capstone Therapeutics announced today it has completed a limited analysis of a subset of data from its ongoing AZX100 Phase 2a clinical trial in trocar site scarring following arthroscopic shoulder surgery. Based on this analysis, the clinical trial will continue to its planned 12-month endpoints.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Heather Hefner, FNP-C 3617 N 103rd Dr, Avondale, AZ 85392-4477 Ph: (972) 935-3444 | Heather Hefner, FNP-C 3617 N 103rd Dr, Avondale, AZ 85392-4477 Ph: (972) 935-3444 |
News Archive
SRI International, an independent nonprofit research and development institute, announced today that Dr. Elizabeth Shriberg, a senior researcher in SRI's Speech Technology and Research (STAR) Laboratory, has been named a Fellow of the International Speech Communication Association (ISCA).
Pregnancy hypertension, or Pre-eclampsia, is a complex disorder of pregnancy. Treatment of elevated blood pressure can manage the condition in the mother, but in severe cases delivery is needed, which can present a major problem to the baby if it is born prematurely.
Avila Therapeutics™, Inc., a biotechnology company developing targeted covalent drugs that treat diseases through protein silencing, presented results of preclinical studies on two of its Hepatitis C Virus protease inhibitors, AVL-181 and AVL-192. These inhibitors, due to their unique mechanism of action with superior selectivity and potency, have potential as best-in-class, pan-genotype HCV therapeutics.
OmniVision Technologies, Inc., a leading developer of advanced digital imaging solutions, today announced a new ultra-compact CameraChip sensor for medical and industrial applications.
Capstone Therapeutics announced today it has completed a limited analysis of a subset of data from its ongoing AZX100 Phase 2a clinical trial in trocar site scarring following arthroscopic shoulder surgery. Based on this analysis, the clinical trial will continue to its planned 12-month endpoints.
› Verified 1 days ago
Mr. Justin Markel Belford, NP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 3426 N 126th Dr, Avondale, AZ 85392 Phone: 623-695-4011 | |
Courtney Standifird, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 10450 W Mcdowell Rd Ste 101, Avondale, AZ 85392 Phone: 623-935-1000 | |
Kia Lambeth, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 10815 W Mcdowell Rd Ste 305, Avondale, AZ 85392 Phone: 623-936-3312 Fax: 623-936-4248 | |
Amy Christine Amore, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 13075 W Mcdowell Rd Ste D106, Avondale, AZ 85392 Phone: 623-547-0522 | |
Mrs. Marytza Olivas-osuna, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 13055 W Mcdowell Rd Ste G112, Avondale, AZ 85392 Phone: 623-322-5900 | |
Joyce Bour, FNP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 12729 W Monte Vista Rd, Avondale, AZ 85392 Phone: 623-792-0209 | |
Bolatito Oyeronke Okougbo, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 10926 W Ivory Ln, Avondale, AZ 85392 Phone: 623-977-7644 |